Cue BiopharmaCUE
13F holders, Q4 2025 (December 31)49holders −3
6new positions
11sold out
1famous investor
$0.31avg. 13F price*
At the end of Q4 2025, 49 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, down 3 from Q3 2025. 6 opened new positions and 11 sold out. The largest holders were Bleichroeder LP ($2.1M), GC Wealth Management RIA, LLC ($1.4M) and Vanguard Group Inc. ($919K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cue Biopharma Inc.
- CUSIP
- 22978P106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $705K |
| Exits | 11 | $138K |
All 13F filers, Q3 2025 → Q4 2025: 4,267,676 shares bought and 538,440 shares sold, net +3,729,236 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Bleichroeder LP | 0.37% | No change | 6,819,164 | $2.1M |
| GC Wealth Management RIA, LLC | 0.05% | Add +35.0% | 4,631,644 | $1.4M |
| Vanguard Group Inc. | 0.00% | Reduce -0.8% | 3,014,034 | $919K |
| Lion Point Capital, LP | 3.48% | New | 2,202,854 | $673K |
| Geode Capital Management, LLC | 0.00% | Add +0.3% | 803,291 | $245K |
| Boothbay Fund Management, LLC | 0.01% | Add +15.3% | 704,297 | $215K |
| Robertson Stephens Wealth Management, LLC | 0.00% | No change | 478,500 | $146K |
| BlackRock, Inc. | 0.00% | No change | 449,162 | $137K |
| Texas Capital Bank Wealth Management Services Inc | 0.01% | Add +1231.3% | 440,670 | $135K |
| Angeles Wealth Management, LLC | 0.01% | Add +158.3% | 310,000 | $95K |
| Advisory Research Inc. | 0.01% | No change | 257,225 | $79K |
| Stifel Financial Corp. | 0.00% | Add +25.4% | 246,556 | $75K |
| Renaissance Technologies | 0.00% | Add +5.0% | 238,354 | $73K |
| Bank of America Corp. | 0.00% | Reduce -36.0% | 207,569 | $63K |
| State Street Corp. | 0.00% | Reduce -5.5% | 179,353 | $55K |
| Susquehanna International Group, LLP | 0.00% | Add +1.4% | 168,829 | $52K |
| Chicago Partners Investment Group LLC | 0.00% | No change | 85,937 | $33K |
| Northern Trust Corp. | 0.00% | No change | 100,958 | $31K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 79,500 | $24K |
| Jane Street Group, LLC | 0.00% | New | 69,793 | $21K |
| UBS Group AG | 0.00% | Reduce -76.5% | 46,848 | $14K |
| LPL Financial LLC | 0.00% | No change | 46,390 | $14K |
| Sigma Planning Corp | 0.00% | Reduce -23.0% | 41,050 | $13K |
| Miramontes Capital, LLC | 0.00% | — | 26,041 | $8K |
| NewEdge Advisors, LLC | 0.00% | No change | 20,000 | $6K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 20,000 | $6K |
| HRT Financial LP | 0.00% | New | 20,863 | $6K |
| Prevail Innovative Wealth Advisors, LLC | 0.00% | No change | 18,987 | $6K |
| Morgan Stanley | 0.00% | Reduce -32.4% | 18,594 | $6K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -0.1% | 14,371 | $4K |
| SeaCrest Wealth Management, LLC | 0.00% | No change | 10,000 | $4K |
| HighTower Advisors, LLC | 0.00% | New | 10,929 | $3K |
| Barclays PLC | 0.00% | No change | 6,029 | $2K |
| Gleason Group, Inc. | 0.00% | No change | 6,000 | $2K |
| New Millennium Group LLC | 0.00% | New | 5,750 | $2K |
| NFSG Corp | 0.00% | No change | 3,000 | $916 |
| Wells Fargo & Company | 0.00% | Reduce -86.9% | 2,563 | $783 |
| Simplex Trading, LLC | 0.00% | Reduce -47.1% | 2,557 | $780 |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,000 | $611 |
| Tidemark, LLC | 0.00% | No change | 1,500 | $458 |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 1,006 | $308 |
| Osaic Holdings, Inc. | 0.00% | No change | 680 | $209 |
| BNP Paribas Financial Markets | 0.00% | Reduce -39.9% | 415 | $127 |
| Jones Financial Companies LLLP | 0.00% | New | 400 | $122 |
| MAI Capital Management | 0.00% | No change | 350 | $107 |
| Torren Management, LLC | 0.00% | — | 324 | $99 |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 120 | $37 |
| IFP Advisors, Inc | 0.00% | No change | 100 | $31 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.6% | 4 | $1 |
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.